Christopher Graybill Joins ARCA as Vice President, Clinical Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. STUB
7. EAT
8. ARX
9. BTGO
10. NVDA

Go back to Christopher Graybill Joins ARCA as Vice President, Clinical Development
ARCA BIOPHARMA (NASDAQ: ABIO) Delayed: 2.40 --0 (-0%)
Previous Close $2.40    52 Week High $6.97 
Open $2.40    52 Week Low $2.15 
Day High $2.40    P/E N/A 
Day Low $2.40    EPS $-1.48 
Volume 148,912